Incyte’s previously disclosed phase 3 win in relapsed or refract | In the phase 3 inMIND study, Monjuvi—added to Bristol ...

研究团队还通过调整水凝胶的力学性质，使其接近天然淋巴组织的硬度。将来自扁桃体的免疫细胞和外周血单个核细胞（PBMC）加入水凝胶中培养，观察其在不同条件下的生发中心反应。结果显示，PBMC来源的类器官能更长时间维持生发中心B细胞（GC B ...

Incyte (Nasdaq: INCY) today announced that the Company will present new data from across its oncology portfolio at the 2024 American Society of Hematology (ASH) Annual Meeting in San Diego.

Dave Coulier has been diagnosed with Stage 3 non-Hodgkin lymphoma. The Full House alum shared the news on TODAY on Wednesday, ...

French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). | French ...

In turn, primary care experts called for a PET scan, CT scan and biopsy. Results then showed he had a “very aggressive” form ...

"Full House" star Dave Coulier, 65, has been diagnosed with stage 3 non-Hodgkin lymphoma, the actor revealed in an exclusive ...

Recent news reveals Full House star Dave Coulier is battling stage 3 lymphoma, drawing attention and concern from fans ...

"Full House" actor Dave Coulier who played Joey Gladstone reveals he has Stage 3 non-Hodgkin lymphoma. He's undergoing ...

This is compared to 83% ... Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non ...

The "Cutaneous T-cell lymphoma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 25+ companies and 30+ ...